Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Anesth Analg. 2020 Aug;131(2):594–604. doi: 10.1213/ANE.0000000000004490

Table 3:

Change in cognitive scores over time before and after post-enrollment exposure to general anesthesia (GA) with or without N2O and estimated difference in change in slope for GA without and with N2O

Cognitive Score GA without N2O* GA with N2O* GA without N2O – GA with N2O
Slope est. Change in slope est. (95% CI) P Change in slope est. (95% CI) P Difference in change in slope est. (95% CI) P
Global z-score −0.075 −0.062 (−0.085, −0.039) <0.001 −0.058 (−0.080, −0.035) <0.001 −0.004 (−0.035 to 0.026) 0.783
Domain specific z-score
 Memory −0.016 −0.073 (−0.100, −0.045) <0.001 −0.064 (−0.089, −0.038) <0.001 −0.009 (−0.044 to 0.027) 0.621
 Language −0.080 −0.002 (−0.024, 0.020) 0.869 −0.029 (−0.050, −0.008) 0.007 0.027 (−0.001 to 0.055) 0.057
 Visuospatial −0.043 −0.003 (−0.023, 0.017) 0.756 −0.005 (−0.025, 0.015) 0.621 0.002 (−0.024 to 0.027) 0.887
 Attention/executive −0.096 −0.052 (−0.080, −0.024) <0.001 −0.051 (−0.075, −0.027) <0.001 −0.001 (−0.036 to 0.034) 0.953

Analyses presented are from adjusted linear mixed effects models. Six participants were excluded from the analyses because of missing covariates. After exclusions there were 1,813 participants included in the analysis (1,278 had not had a subsequent or new exposure prior to censoring, 280 had a subsequent or new exposure to GA without N2O, and 255 had a subsequent or new exposure to GA with N2O). All models are adjusted for prior 20-year exposure to GA without N2O, GA with N2O, age, sex, cognitive status at enrollment, education, marital status, Charlson comorbidity index, presence of APOE-ε4 genotype, ever-diagnosed alcohol problem, smoking status, mid-life diagnosis of diabetes, hypertension, and dyslipidemia, and history of atrial fibrillation, congestive heart failure, stroke, and coronary artery disease.

Slope estimate represents average annual change (slope) in z-score for participants prior to any post-enrollment exposure to surgery/GA.

*

Estimates, 95% confidence intervals, and P-values for the time-dependent change in slope following new exposure to GA without and with N2O based on a post-enrollment exposure;

P-value for comparison of change in slope estimates between GA without and with N2O.